Randal Chase

Biography

Dr. Chase has more than 40 years of experience in biotechnology and related fields. Randal began his career at Bristol Meyers and Glaxo Canada Inc., where he held the positions of Director and Senior Vice President, respectively. He is a former President of several companies, including Quadra Logic Technologies, Inc., North American Vaccine and Aventis Pasteur Canada. As well, Dr. Chase has served as President and Chief Executive Officer of ImmunoVaccine Technologies Inc. from 2006 to 2011. From 2005 to 2006, he was Chairman of the Board of Directors of Molecular Templates Inc. From 2001 to 2004, Dr. Chase was President of Shire Biologics Inc and from May 2001 to August 2002, he served as Senior Vice-President, Vaccines Operations of Biochem Pharma Inc. Among his numerous appointments, Dr. Chase has been a member of the board of Biotech Canada, and has served as a Director of Bioject Medical Technologies, Inc. (NASDAQ), Acambis PLC (London Stock Exchange, NASDAQ), and of Conjuchem Inc. and of Conjuchem Biotechnologies Inc. (TSX). Most recently, Dr. Chase was Chairman of the Board and Director of Medicago. He currently serves as Chairman of MediMabs, a privately held company, and is a member of the Board of Geovax Labs, Inc., a vaccine company trading on the OTCQX. Dr. Chase has more than 40 years of experience in biotechnology and related fields. Randal began his career at Bristol Meyers and Glaxo Canada Inc., where he held the positions of Director and Senior Vice President, respectively. He is a former President of several companies, including Quadra Logic Technologies, Inc., North American Vaccine and Aventis Pasteur Canada. As well, Dr. Chase has served as President and Chief Executive Officer of ImmunoVaccine Technologies Inc. from 2006 to 2011. From 2005 to 2006, he was Chairman of the Board of Directors of Molecular Templates Inc. From 2001 to 2004, Dr. Chase was President of Shire Biologics Inc and from May 2001 to August 2002, he served as Senior Vice-President, Vaccines Operations of Biochem Pharma Inc. Among his numerous appointments, Dr. Chase has been a member of the board of Biotech Canada, and has served as a Director of Bioject Medical Technologies, Inc. (NASDAQ), Acambis PLC (London Stock Exchange, NASDAQ), and of Conjuchem Inc. and of Conjuchem Biotechnologies Inc. (TSX). Most recently, Dr. Chase was Chairman of the Board and Director of Medicago. He currently serves as Chairman of MediMabs, a privately held company, and is a member of the Board of Geovax Labs, Inc., a vaccine company trading on the OTCQX.

Research Interest

Biochemistry